Deep Value: cash covers more than 100% of the stock price

This company holds roughly $30M in cash and investments — more than its entire stock-market value, based on its latest quarterly filing. You're paying very little for the actual business. Sometimes that's a genuine bargain or a takeover target, sometimes it's cheap for a reason. Not a buy signal on its own — always ask why it's this cheap.

Jin Medical International

ZJYL

Medical - Instruments & Supplies · Healthcare

Exchange

NASDAQ Capital Market

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Mar 31, 2026

How the score breaks down

Quality

Weak

Growth

Weak

Cash Flow

Weak

Stability

Strong

Valuation

Mixed

Track this stock — start free trial

Winston Score History

The full picture

Jin Medical International Ltd. is a Chinese company that makes mobility aids and rehabilitation equipment. Its main products include wheelchairs, walking aids, and related assistive devices. The company sells primarily to hospitals, rehabilitation centers, and individual patients across China, serving an aging population that increasingly needs help with movement and daily living.

Jin Medical earns revenue by manufacturing and selling its products directly and through distributors. It operates mainly in China, which is one of the world's largest and fastest-growing markets for elderly care products due to its rapidly aging population. The company is small, with a near-zero market cap, thin operating margins around 2%, and a very low return on invested capital, which suggests limited pricing power and intense competition from both domestic and international medical device makers. The key risk is that the company must scale efficiently in a crowded market while managing costs, as its current profitability leaves little room for error.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-9.7% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-15.0% YoY

YoY Growth Rate

Earnings declining

Insider Activity

76.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~3 years

$30M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$30M cash & investments at current burn rate

Revenue declining

Jin Medical International's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

26.9%

Modest — 26.9% gross margin

Profit after running costs

Operating Margin

-7.2%

Losing money on operations — -7.2%

Return on the money invested

ROCE

0.8%

Weak — 0.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-13.6%

Shrinking sales (-13.6% YoY)

Profit growth

EPS YoY

-35.9%

Earnings shrinking (-35.9% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

-51%

Weak — only -51% of profit becomes cash

Spare cash per sale

FCF Margin

-35.3%

Burning cash (-35.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.68

Moderate — manageable debt (0.68)

Covers its interest

Interest Cover

100.00x

Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

20.8x

no trend

Growth-priced — P/E 20.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial